Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Integrative Transcriptomic and Metabonomic Molecular Profiling of Colonic Mucosal Biopsies Indicates a Unique Molecular Phenotype for Ulcerative Colitis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Managing vitamin D deficiency in inflammatory bowel disease

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Metabonomics in Gastroenterology and Hepatology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Methotrexate for inflammatory bowel disease: time for reconsideration

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Ulcerative colitis is the most prevailing entity of several disorders under the umbrella term inflammatory bowel disease, with potentially serious symptoms and devastating consequences for affected patients. The exact molecular etiology of ulcerative colitis is not yet revealed. In this study, we characterized the molecular phenotype of ulcerative colitis through transcriptomic and metabonomic profiling of colonic mucosal biopsies from patients and controls. We have characterized the extent to which metabonomic and transcriptomic molecular phenotypes are associated with ulcerative colitis versus controls and other disease-related phenotypes such as steroid dependency and age at diagnosis, to determine if there is evidence of enrichment of differential expression in candidate genes from genome-wide association studies and if there are particular pathways influenced by disease-associated genes. Both transcriptomic and metabonomic data have previously been shown to predict the clinical course of ulcerative colitis and related clinical phenotypes, indicating that molecular phenotypes reveal molecular changes associated with the disease. Our analyses indicate that variables of both transcriptomics and metabonomics are associated with disease case and control status, that a large proportion of transcripts are associated with at least one metabolite in mucosal colonic biopsies, and that multiple pathways are connected to disease-related metabolites and transcripts.

OriginalsprogEngelsk
TidsskriftJournal of Proteome Research
Vol/bind14
Udgave nummer1
Sider (fra-til)479–490
ISSN1535-3893
DOI
StatusUdgivet - 2015

ID: 44849313